These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18090485)

  • 1. Nonablative minimally invasive thermal therapies in the treatment of symptomatic benign prostatic hyperplasia.
    d'Ancona FC
    Curr Opin Urol; 2008 Jan; 18(1):21-7. PubMed ID: 18090485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
    Stovsky MD; Griffiths RI; Duff SB
    J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermotherapy and thermoablation for benign prostatic hyperplasia.
    Gravas S; Laguna P; de la Rosette J
    Curr Opin Urol; 2003 Jan; 13(1):45-9. PubMed ID: 12490815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update in minimal invasive therapy in benign prostatic hyperplasia.
    Van Hest P; D'Ancona F
    Minerva Urol Nefrol; 2009 Sep; 61(3):257-68. PubMed ID: 19773727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of prostatic stents and transurethral microwave thermotherapy in the treatment of voiding disorders related to benign prostatic hyperplasia (CTMH-AFU forum 2005)].
    ; Saussine C; Devonec M; Haillot O; Fourmarier M; Desgrandchamps F; Ballereau C; Azzouzi AR; Lukacs B; de la Taille A
    Prog Urol; 2006 Nov; 16(5):533-6. PubMed ID: 17175945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.
    Yu X; Elliott SP; Wilt TJ; McBean AM
    J Urol; 2008 Jul; 180(1):241-5; discussion 245. PubMed ID: 18499180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of treatment for benign prostatic hyperplasia: an economic model for comparison of medical, minimally invasive, and surgical therapy.
    Manyak MJ; Ackerman SJ; Blute ML; Rein AL; Buesterien K; Sullivan EM; Tanio CP; Strauss MJ
    J Endourol; 2002 Feb; 16(1):51-6. PubMed ID: 11890452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
    Rosario DJ; Phillips JT; Chapple CR
    J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transurethral microwave thermotherapy: from evidence-based medicine to clinical practice.
    Gravas S; Melekos MD
    Curr Opin Urol; 2007 Jan; 17(1):12-6. PubMed ID: 17143105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update of the minimally invasive therapies for benign prostatic hyperplasia.
    Naspro R; Salonia A; Colombo R; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    Curr Opin Urol; 2005 Jan; 15(1):49-53. PubMed ID: 15586031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimally invasive therapy for benign prostatic hyperplasia: practice patterns in Minnesota.
    Ercole B; Lee C; Best S; Fallon E; Skenazy J; Monga M
    J Endourol; 2005 Mar; 19(2):159-62. PubMed ID: 15798410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in minimally invasive treatment of benign prostatic hyperplasia].
    Yu B; Wang Z
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):739-43. PubMed ID: 17918717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transurethral resection versus minimally invasive treatments of benign prostatic hyperplasia: results of treatments. Our experience.
    Minardi D; Galosi AB; Yehia M; Cristalli A; Hanitzsch H; Polito M; Muzzonigro G
    Arch Ital Urol Androl; 2004 Mar; 76(1):11-8. PubMed ID: 15185816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options for benign prostatic hyperplasia in older men.
    Miano R; De Nunzio C; Asimakopoulos AD; Germani S; Tubaro A
    Med Sci Monit; 2008 Jul; 14(7):RA94-102. PubMed ID: 18591930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durability and retreatment rates of minimal invasive treatments of benign prostatic hyperplasia: a cross-analysis of the literature.
    Djavan B; Eckersberger E; Handl MJ; Brandner R; Sadri H; Lepor H
    Can J Urol; 2010 Aug; 17(4):5249-54. PubMed ID: 20735902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and assessment of minimally invasive approaches to benign prostatic hyperplasia therapy.
    Larson TR
    Urology; 2002 Feb; 59(2 Suppl 1):12-6. PubMed ID: 11832309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally invasive therapies for benign prostatic hyperplasia.
    Tunuguntla HS; Evans CP
    World J Urol; 2002 Sep; 20(4):197-206. PubMed ID: 12215846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel intraurethral prostatic bridge catheter for prevention of temporary prostatic obstruction following high energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia.
    Djavan B; Fakhari M; Shariat S; Ghawidel K; Marberger M
    J Urol; 1999 Jan; 161(1):144-51. PubMed ID: 10037387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally invasive therapies for benign prostatic hyperplasia in the new millennium: long-term data.
    Zlotta AR; Djavan B
    Curr Opin Urol; 2002 Jan; 12(1):7-14. PubMed ID: 11753127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological changes of minimally invasive procedures for the treatment of benign prostatic hyperplasia and prostate cancer: clinical implications.
    Larson BT; Bostwick DG; Corica AG; Larson TR
    J Urol; 2003 Jul; 170(1):12-9. PubMed ID: 12796636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.